| Date Filed | Type | Description |
| 08/03/2023 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Granted 1,122 shares
@ $0 |
|
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Bought 10,000 shares
@ $9.1048, valued at
$91k
|
|
| 06/27/2022 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $16.02, valued at
$240.3k
|
|
| 01/26/2022 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 15,568 shares
@ $0
Granted 22,727 options to buy
@ $5.46, valued at
$124.1k
|
|
| 11/22/2021 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Granted 478 shares
@ $0
Granted 1,695 options to buy
@ $263.16, valued at
$446.1k
|
|
| 11/15/2021 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Paid exercise price by delivering 342 shares
@ $259.47, valued at
$88.7k
|
|
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $35.09, valued at
$526.4k
|
|
| 02/09/2021 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 19,313 shares
@ $0 |
|
| 11/20/2020 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Granted 1,187 shares
@ $0 |
|
| 11/13/2020 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Paid exercise price by delivering 579 shares
@ $212.11, valued at
$122.8k
|
|
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2020 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 23,458 options to buy
@ $10.19, valued at
$239k
|
|
| 11/25/2019 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Granted 1,727 shares
@ $0 |
|
| 10/29/2019 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $10.23, valued at
$153.5k
|
|
| 08/21/2019 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Bought 4,681 shares
@ $11.02, valued at
$51.6k
Bought 4,432 shares
@ $10.85, valued at
$48.1k
|
|
| 07/17/2019 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Evolus, Inc.|
Txns:
| Granted 26,163 options to buy
@ $15.99, valued at
$418.3k
|
|
| 07/17/2019 |
3
| FARRELL PETER C (Director) has filed a Form 3 on Evolus, Inc. |
| 01/02/2019 |
3
| FARRELL PETER C (Director) has filed a Form 3 on Arcturus Therapeutics Ltd. |
| 12/13/2018 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Gifted 13,866 shares
@ $115.395, valued at
$1.6M
|
|
| 11/16/2018 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Paid exercise price by delivering 729 shares
@ $106.94, valued at
$78k
Granted 11,442 options to buy
@ $101.64, valued at
$1.2M
|
|
| 05/07/2018 |
4
| FARRELL PETER C (Director) has filed a Form 4 on NUVASIVE INC|
Txns:
| Exercised 16,844 shares
@ $0
Exercised 6,000 shares
@ $39.45, valued at
$236.7k
Paid exercise price by delivering 4,777 shares
@ $49.54, valued at
$236.7k
Exercised 2,833 options to buy
@ $0
Exercised 3,725 options to buy
@ $0
Exercised 2,501 options to buy
@ $0
Exercised 2,822 options to buy
@ $0
Exercised 2,130 options to buy
@ $0
Exercised 6,000 options to buy
@ $39.45, valued at
$236.7k
|
|
| 12/18/2017 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Gifted 23,689 shares
@ $84.43, valued at
$2M
Gifted 1,180 shares
@ $84.97, valued at
$100.3k
Gifted 3,351 shares
@ $86, valued at
$288.2k
|
|
| 11/29/2017 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Gifted 2,948 shares
@ $84.8, valued at
$250k
|
|
| 11/17/2017 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Granted 2,991 shares
@ $84.98, valued at
$254.2k
|
|
| 11/13/2017 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Sold 11,815 shares
@ $82.71, valued at
$977.2k
Sold 20,492 shares
@ $82.7, valued at
$1.7M
Sold 3,625 shares
@ $82.69, valued at
$299.8k
Sold 82,460 shares
@ $82.7, valued at
$6.8M
Paid exercise price by delivering 1,858 shares
@ $83.06, valued at
$154.3k
Exercised 11,815 options to buy
@ $52.02, valued at
$614.6k
Exercised 20,492 options to buy
@ $58.24, valued at
$1.2M
Exercised 3,625 options to buy
@ $27.58, valued at
$100k
Exercised 82,460 options to buy
@ $27.58, valued at
$2.3M
|
|
| 11/08/2017 |
4
| FARRELL PETER C (Director) has filed a Form 4 on RESMED INC|
Txns:
| Sold 18,000 shares
@ $83.497, valued at
$1.5M
Sold 2,000 shares
@ $83.817, valued at
$167.6k
Exercised 20,000 options to buy
@ $27.58, valued at
$551.6k
|
|
| 10/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|